154 related articles for article (PubMed ID: 20034026)
21. [Inhibitory effect of 5-aminoisoquinolinone on PARP activity in colon carcinoma cell line HT-29].
Hao LX; Wang YL; Cai L; Li YY
Ai Zheng; 2007 Jun; 26(6):566-71. PubMed ID: 17562258
[TBL] [Abstract][Full Text] [Related]
22. Poly (ADP-ribose) polymerase inhibitor reduces heart ischaemia/reperfusion injury via inflammation and Akt signalling in rats.
Song ZF; Chen DY; DU B; Ji XP
Chin Med J (Engl); 2013; 126(10):1913-7. PubMed ID: 23673109
[TBL] [Abstract][Full Text] [Related]
23. Nicotinamide inhibits the early stage of carcinogen-induced hepatocarcinogenesis in mice and suppresses human hepatocellular carcinoma cell growth.
Park SY; Lee KB; Lee MJ; Bae SC; Jang JJ
J Cell Physiol; 2012 Mar; 227(3):899-908. PubMed ID: 21503886
[TBL] [Abstract][Full Text] [Related]
24. [Effects of Rapamycin on angiogenesis and tumor progression in human hepatocellular carcinoma implantation mice].
Zhang J; Li H; Wang GS; Jiang N; Yang Y; Chen GH
Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(18):1403-5. PubMed ID: 20092777
[TBL] [Abstract][Full Text] [Related]
25. [Effects of sirolimus on the growth of transplanted hepatocellular carcinoma].
Zhang J; Li H; Wang GS; Jiang N; Yang Y; Chen GH
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):413-6. PubMed ID: 19567017
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of poly(ADP-ribose) glycohydrolase by gallotannin selectively up-regulates expression of proinflammatory genes.
Rapizzi E; Fossati S; Moroni F; Chiarugi A
Mol Pharmacol; 2004 Oct; 66(4):890-8. PubMed ID: 15229295
[TBL] [Abstract][Full Text] [Related]
27. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
Tan HY; Wang N; Tsao SW; Zhang Z; Feng Y
Integr Cancer Ther; 2014 Sep; 13(5):425-34. PubMed ID: 24363282
[TBL] [Abstract][Full Text] [Related]
28. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.
Blivet-Van Eggelpoël MJ; Chettouh H; Fartoux L; Aoudjehane L; Barbu V; Rey C; Priam S; Housset C; Rosmorduc O; Desbois-Mouthon C
J Hepatol; 2012 Jul; 57(1):108-15. PubMed ID: 22414764
[TBL] [Abstract][Full Text] [Related]
32. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.
Peralta-Leal A; Rodríguez-Vargas JM; Aguilar-Quesada R; Rodríguez MI; Linares JL; de Almodóvar MR; Oliver FJ
Free Radic Biol Med; 2009 Jul; 47(1):13-26. PubMed ID: 19362586
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
Kaplan J; O'Connor M; Hake PW; Zingarelli B
Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of perifosine alone and in combination with sorafenib in an HrasG12V plus shp53 transgenic mouse model of hepatocellular carcinoma.
Kim MN; Ro SW; Kim DY; Kim da Y; Cho KJ; Park JH; Lim HY; Han KH
Cancer Chemother Pharmacol; 2015 Aug; 76(2):257-67. PubMed ID: 26037205
[TBL] [Abstract][Full Text] [Related]
35. Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma.
Zai W; Chen W; Han Y; Wu Z; Fan J; Zhang X; Luan J; Tang S; Jin X; Fu X; Gao H; Ju D; Liu H
Carcinogenesis; 2020 May; 41(3):345-357. PubMed ID: 31175354
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
Sun Y; Zhou L; Lv D; Liu H; He T; Wang X
Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):422-30. PubMed ID: 25926140
[TBL] [Abstract][Full Text] [Related]
37. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
Wang Z; Fan J; Zhou J; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1666-70. PubMed ID: 16854316
[TBL] [Abstract][Full Text] [Related]
38. Parp-1 deficiency does not enhance liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice.
Ogawa K; Masutani M; Kato K; Tang M; Kamada N; Suzuki H; Nakagama H; Sugimura T; Shirai T
Cancer Lett; 2006 May; 236(1):32-8. PubMed ID: 15955622
[TBL] [Abstract][Full Text] [Related]
39. 5-Aminoisoquinolinone reduces the expression of vascular endothelial growth factor-C via the nuclear factor-κB signaling pathway in CT26 cells.
Wu WQ; Fauzee NJ; Wang YL
Asian Pac J Cancer Prev; 2012; 13(3):991-4. PubMed ID: 22631685
[TBL] [Abstract][Full Text] [Related]
40. EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma.
Dong Q; Du Y; Li H; Liu C; Wei Y; Chen MK; Zhao X; Chu YY; Qiu Y; Qin L; Yamaguchi H; Hung MC
Cancer Res; 2019 Feb; 79(4):819-829. PubMed ID: 30573522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
